MB

Michael Baran

Partner - Pfizer Ventures

New York City Metropolitan Area

Investor
VC

Invests in

Locations:

New York City

  • Min Investment:

    $100,000.00

  • Max Investment:

    $15,000,000.00

  • Target Investment:

    $10,000,000.00

Skills

Commercialization
Lifesciences
Drug Discovery
Biopharmaceuticals
Biochemistry
Pharmaceutical Industry
Clinical Development
Biotechnology
Oncology
Clinical Trials
CRO
Managed Care
Technology Transfer
Medical Devices
Infectious Diseases
FDA
Pharmaceutics
Clinical Research
Immunology
Regulatory Affairs

Education

Lists including Michael

AM
AR
AG
AH

Based in NYC

2600 people

AT
AS
AT
AH

All Series A Investors

14752 people

AM
AT
AS
AR

All Seed Investors

19695 people

AT
AE
AE
AL

All Pre-Seed Investors

7974 people

Investments

Capstan Therapeutics

Series A

Total Funding: $280M

VitaDAO

Seed

Total Funding: $4.5M

ImCheck Therapeutics

Series B

Total Funding: $180M

ImmunOs Therapeutics

Series A

Total Funding: $88M

Work Experience

P
Pfizer

2008

  • Partner, Pfizer Ventures

    2018

  • Executive Director, Emerging Science & Innovation, Oncology

    2018 - 2018

  • Senior Director, Strategic Portfolio Management

    2017 - 2018

  • Senior Director, External R&D Innovation - Asia Pacific Strategy

    2013 - 2018

  • Senior Director, Scientific Affairs - Office of the R&D President

    2011 - 2017

  • Director, Customer Analytics

    2009 - 2011

  • Director, Contract Strategy & Information Group

    2008 - 2009

SB
Stony Brook University

2020

  • Adjunct Assistant Professor - Department of Biomedical Engineering

    2020

IT
Imcheck Therapeutics

2019

  • Board of Directors

    2019

IT
ImmunOs Therapeutics AG

2019

  • Board of Directors

    2019

AT
Autobahn Therapeutics, Inc.

2020

  • Board of Directors Observer

    2020

MT
Mediar Therapeutics

2021

  • Board of Directors

    2021

IB
Interius Biotherapeutics

2021

  • Board of Directors Observer

    2021

AB
Anjarium Biosciences

2021

  • Board of Directors Observer

    2021

PT
Parthenon Therapeutics

2021

  • Board of Directors Observer

    2021

T
TRexBio

2021

  • Board of Directors

    2021